Sina Mohammadinejad
Overview
Explore the profile of Sina Mohammadinejad including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
84
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mohammadinejad S, Jafari-Gharabaghlou D, Zarghami N
Asian Pac J Cancer Prev
. 2022 Dec;
23(12):4063-4072.
PMID: 36579986
Objective: The incidence of breast cancer continues to rise despite decades of laboratory, epidemiological and clinical research. Breast cancer is still the leading cause of cancer death in women. Cyclin...
2.
Madadi S, Mohammadinejad S, Alizadegan A, Hojjat-Farsangi M, Dolati S, Kafil H, et al.
Hum Immunol
. 2022 Jul;
83(8-9):628-636.
PMID: 35906120
Preeclampsia (PE) is a severe complication in pregnancy, and its symptoms (proteinuria and hypertension) manifest after 20 weeks of gestation, affecting up to 8 % of pregnancies. The pregnant women's...
3.
Alizadegan A, Akbarzadeh M, Soltani-Zangbar M, Sambrani R, Hamdi K, Ghasemzadeh A, et al.
BMC Res Notes
. 2022 Jul;
15(1):259.
PMID: 35842732
Objectives: This investigation aims to evaluate the association between the concentration of cell-free DNA (cfDNA) in the spent culture medium (SCM) with implantation rate and the maternal immune system in...
4.
Kachalaki S, Ebrahimi M, Mohamed Khosroshahi L, Mohammadinejad S, Baradaran B
Eur J Pharm Sci
. 2016 Apr;
89:20-30.
PMID: 27094906
The effectiveness of chemotherapy is one of the main challenges in cancer treatment and resistance to classic drugs and traditional treatment processes is an obstacle to this goal. Drug resistance...
5.
Kachalaki S, Baradaran B, Majidi J, Yousefi M, Shanehbandi D, Mohammadinejad S, et al.
Biomed Pharmacother
. 2015 Oct;
75:100-4.
PMID: 26463638
Background: Overexpression of ATP-binding cassette (ABC) drug transporters is a major barrier in the success of cancer chemotherapy. One way to overcome overexpression of ABC drug transporter-mediated chemoresistance in acute...
6.
Mohammadinejad S, Akbarzadeh A, Rahmati-Yamchi M, Hatam S, Kachalaki S, Zohreh S, et al.
Asian Pac J Cancer Prev
. 2015 May;
16(9):3753-8.
PMID: 25987033
Background: Polymeric nanoparticles are attractive materials that have been widely used in medicine for drug delivery, with therapeutic applications. In our study, polymeric nanoparticles and the anticancer drug, chrysin, were...